ConductScience.org, home

Trial · NCT01773993

Results by group28

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Percentage of Participants With Adverse Drug ReactionLYRICA Capsules (Pregabalin)25.45Percentage of Participants
Percentage of Participants With Serious Adverse Drug ReactionLYRICA Capsules (Pregabalin)0.20Percentage of Participants
Percentage of Participants With Adverse Drug Reaction Unexpected From Japanese Package InsertLYRICA Capsules (Pregabalin)3.41Percentage of Participants
Number of Participants With Adverse Drug Reactions Related to Peripheral Edema or Other Edema-related EventsLYRICA Capsules (Pregabalin)6Participants
Number of Participants With Adverse Drug Reactions Related to Dizziness, Somnolence, Loss of Consciousness, Syncope, and Potential for Accidental InjuryLYRICA Capsules (Pregabalin)65Participants
Number of Participants With Adverse Drug Reactions Related to Vision-related EventsLYRICA Capsules (Pregabalin)5Participants
Change From Baseline in Pain Score at Week 52LYRICA Capsules (Pregabalin)-2.4Standard Deviation 2.67Units on a scale
Change From Baseline in Quality of Sleep Score at Week 52LYRICA Capsules (Pregabalin)-1.4Standard Deviation 2.71Units on a scale
Patient's Impression (PGIC) at Week 52LYRICA Capsules (Pregabalin)Markedly improved34Participants
Patient's Impression (PGIC) at Week 52LYRICA Capsules (Pregabalin)Improved79Participants
Patient's Impression (PGIC) at Week 52LYRICA Capsules (Pregabalin)Slightly improved119Participants
Patient's Impression (PGIC) at Week 52LYRICA Capsules (Pregabalin)Unchanged65Participants
Patient's Impression (PGIC) at Week 52LYRICA Capsules (Pregabalin)Slightly worsened6Participants
Patient's Impression (PGIC) at Week 52LYRICA Capsules (Pregabalin)Worsened3Participants
Patient's Impression (PGIC) at Week 52LYRICA Capsules (Pregabalin)Markedly worsened1Participants
Patient's Impression (PGIC) at Week 52LYRICA Capsules (Pregabalin)Not assessed109Participants
Physician's Impression (CGIC) at Week 52LYRICA Capsules (Pregabalin)Markedly improved45Participants
Physician's Impression (CGIC) at Week 52LYRICA Capsules (Pregabalin)Improved105Participants
Physician's Impression (CGIC) at Week 52LYRICA Capsules (Pregabalin)Slightly improved121Participants
Physician's Impression (CGIC) at Week 52LYRICA Capsules (Pregabalin)Unchanged59Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01773993/results